Upconversion Nanoparticles for Bioimaging and Regenerative Medicine by María González-Béjar et al.
June 2016 | Volume 4 | Article 471
Mini Review
published: 13 June 2016
doi: 10.3389/fbioe.2016.00047
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org
Edited by: 
Brian McNeill, 
University of Ottawa 
Heart Institute, Canada
Reviewed by: 
Michael Ming-Yuan Wei, 
University of Texas at Arlington, USA 
Sabrina Simoncelli, 
Ludwig-Maximilians-Universität 
Munchen, Germany
*Correspondence:
María González-Béjar  
maria.gonzalez@uv.es; 
Julia Pérez-Prieto  
julia.perez@uv.es
Specialty section: 
This article was submitted 
to Biomaterials, 
a section of the journal 
Frontiers in Bioengineering and 
Biotechnology
Received: 30 March 2016
Accepted: 23 May 2016
Published: 13 June 2016
Citation: 
González-Béjar M, Francés-Soriano L 
and Pérez-Prieto J (2016) 
Upconversion Nanoparticles for 
Bioimaging and Regenerative 
Medicine. 
Front. Bioeng. Biotechnol. 4:47. 
doi: 10.3389/fbioe.2016.00047
Upconversion nanoparticles 
for Bioimaging and Regenerative 
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Nanomaterials are proving useful for regenerative medicine in combination with stem 
cell therapy. Nanoparticles (NPs) can be administrated and targeted to desired tissues 
or organs and subsequently be used in non-invasive real-time visualization and tracking 
of cells by means of different imaging techniques, can act as therapeutic agent nano-
carriers, and can also serve as scaffolds to guide the growth of new tissue. NPs can be 
of different chemical nature, such as gold, iron oxide, cadmium selenide, and carbon, 
and have the potential to be used in regenerative medicine. However, there are still many 
issues to be solved, such as toxicity, stability, and resident time. Upconversion NPs have 
relevant properties such as (i) low toxicity, (ii) capability to absorb light in an optical region 
where absorption in tissues is minimal and penetration is optimal (note they can also be 
designed to emit in the near-infrared region), and (iii) they can be used in multiplexing 
and multimodal imaging. An overview on the potentiality of upconversion materials in 
regenerative medicine is given.
Keywords: transparency, niR excitation, upconverted (Uv–viS–niR) emission, non-toxic nanoparticles,  multi-
wavelength/multimodal bioimaging, cell behavior regulation
inTRODUCTiOn
Regenerative medicine aims to maintain, regenerate, and replace damaged or non-functional human 
cells, tissues, or organs to restore normal functions (Engel et  al., 2008; Harrison and Sirivisoot, 
2011; Gao et al., 2015; Mitragotri et al., 2015) via stimulating the body’s own repair mechanisms. 
In this context, nanostructures can play an important role regarding implants or scaffolds for tissue 
engineering and cell therapies, e.g., nanopatterning of surfaces to elicit specific biological responses 
from the host tissue and organs (Engel et al., 2008; Zhang and Webster, 2009; Harrison and Sirivisoot, 
2011). Thus, the generation of new surfaces, structures, and materials containing nanoparticles 
(NPs) can provide the possibility of mimicking the natural environment of cells and promoting 
certain functions, such as cell mobility, cell adhesion, and cell differentiation that would be directly 
related to the nanotopography of the biomaterial (Engel et al., 2008).
The capability of nanomaterials to be multifunctional, as they can consist of different functional 
components in a single unit, is leading to significant advances over traditional imaging, sensing, and 
structural technologies (Harrison and Sirivisoot, 2011). Thus, NPs are used in biomedical applica-
tions for imaging (cell tracking and visualization), therapy, drug delivery aimed at target biological 
functions, surface modifications of implantable materials, diagnosis (Engel et al., 2008; Harrison and 
Sirivisoot, 2011; Gao et al., 2015), and even in the regulation of cell behavior (adhesion, growth, and 
differentiation), which is of relevance in regenerative medicine (Mitragotri et al., 2015).
New smart biomaterials could be implanted to monitor and direct the regenerative process at the 
cellular level. For example, NPs could help to monitor a disease (e.g., via emission or magnetism) and 
bring about tissue repair (e.g., through light-induced targeted delivery) creating better non-invasive 
regenerative therapies (Harrison and Sirivisoot, 2011; Gao et al., 2015). Interestingly, stem cells have 
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the ability to generate all types of tissues together with an unlim-
ited self-renewal capacity; hence, research is focused on being 
able to locate, recruit, and mark these cells to monitor and/or 
trigger the regeneration process (Harrison and Sirivisoot, 2011).
Nanoparticles are also being explored as nanocarriers for 
theranostic applications (Grazú et al., 2012; Muthu et al., 2014). 
This new field integrates NP design with simultaneous imaging 
and therapy, aiming to offer individualized treatments based on 
in vivo molecular images to allow for a comprehensive diagnosis 
(Rai et al., 2010). Several NPs have been used as platforms for 
NP-based theranostics (Choi et al., 2012; Miao et al., 2016): gold 
nanoparticles (GNPs) (Gao and Li, 2016), carbon nanotubes 
(CNTs) (Tran et  al., 2009; Yun et  al., 2012; Fraczek-Szczypta, 
2014), magnetic NPs (MNPs) (Gao et al., 2015), silica NPs (SNPs) 
(Santra et  al., 2005; Vivero-Escoto et  al., 2012), quantum dots 
(QDs) (Ho and Leong, 2010), and upconversion NPs (UCNPs) 
(Chen et  al., 2014a), among others. Remarkably, it has been 
estimated that at least half of the drugs used in 2020 will be based 
on nanotechnology (Grazú et al., 2012).
Current methods of evaluating cell treatments typically 
involve destructive or invasive techniques, such as tissue biopsies, 
whereas traditional non-invasive methods, such as magnetic reso-
nance imaging (MRI) and positron emission tomography (PET), 
rely heavily on contrast agents and usually lack the specificity or 
resident time to be a viable option for cell tracking (Engel et al., 
2008; Harrison and Sirivisoot, 2011). Photonic applications for 
diagnostics, therapy, and interventional guidance are increasing 
(Jin et al., 2011; Rwei et al., 2015). Fiber-optic based catheters can 
be used to perform localized imaging or laser ablation of a desired 
target to treat, for example, coronary artery disease (van Soest 
et al., 2015). Moreover, irradiation density is easy to dose and can 
provide spatiotemporal control (Rwei et al., 2015; van Soest et al., 
2015). The limitations of biophotonic technologies for imaging 
usually arise from limited penetration depth of light into tissues; 
however, penetration depth could reach the centimeter scale for 
applications that rely on near-infrared (NIR) wavelengths and on 
optical power (diffuse optics and sensing) (Rwei et al., 2015; van 
Soest et al., 2015). UCNPs are transparent to visible light but can 
absorb two or more photons in the NIR region and emit at a higher 
energy level via a non-linear conversion process. Therefore, these 
luminescent NPs enable high-contrast optical biomedical imag-
ing by suppressing the background of tissue autofluorescence and 
avoiding high absorption of the tissue.
In this mini-review, an overview of the use of NPs in regenera-
tive medicine and what UCNPs can offer to this field is given.
nAnOPARTiCLeS in BiOMeDiCine
Nanoparticles used in biomedicine must be biocompatible, 
water-dispersible, and stable in physiological media (Mu et al., 
2014). To date, most of the ongoing nanomedicine clinical 
trials or those already on the market are being injected and 
provide passive drug targeting (Li et al., 2010; Grazú et al., 2012; 
Markovsky et al., 2012; Rwei et al., 2015). Therefore, the stability 
of nanocarriers in biological media is crucial when formulating 
nanomedicines (Acharya and Sahoo, 2011; Wu et  al., 2011). 
Their aggregation and rapid clearance have to be avoided 
(Veiseh et al., 2010), and their pharmacokinetic profile should 
be studied in advance (Grazú et al., 2012). Equally important, it 
is extremely difficult for a nanoplatform to selectively reach its 
target site (Wu et al., 2011). Currently, the most universal way 
to improve its affinity toward a target is by attachment of ligands 
[RGD (Zhou et  al., 2012), antigen, and folate] that selectively 
recognize and bind to the target site. This active targeting, which 
relies on specific interactions, can lead to the accumulation of the 
nanoplatforms preferentially in, e.g., a tumor region, an ischemic 
tissue, or an inflamed area as a result of their extravasation 
through permeable vasculature, an effect known as enhanced 
permeation and retention (EPR) (Maeda, 2001; Hartner et al., 
2009; Albanese et al., 2012).
Multifunctional NPs have been used to design biomaterials and 
nanoplatforms able to entrap and deliver drugs and biomolecules 
(such as DNA and growth and differentiation factors, among oth-
ers bioactive agents) to cells and tissues, for the effective imple-
mentation of regenerative therapies (Panyam and Labhasetwar, 
2003; Solanki et al., 2008; Grazú et al., 2012). For example, GNPs 
conjugated with a DNA–polymer complex have been used as 
nanoscaffolds for delivery of DNA into hMSCs through reverse 
transfection (Uchimura et al., 2007). They have also been used as 
a reinforcing- or bioactivity-enhancement phase for polymeric 
matrices in 3D scaffolds for tissue engineering (Reddy et al., 2006; 
Engel et al., 2008).
Nanocarriers designed for delivery are able to bypass bio-
logical barriers, such as cell membranes and the blood–brain 
barrier, and can be loaded with high drug concentrations of 
therapeutics to be released. Once the target site is reached, 
therapeutic drugs must be delivered from the nanocarrier in 
order to become bioavailable and aid the regeneration process 
(Qiu and Park, 2001). Passive processes, such as diffusion, par-
ticle erosion, particle degradation, and polymer swelling, can 
control the release (Mudshinge et al., 2011). The nanoplatform 
has to be stable enough to promote controlled release of cargo 
exclusively when triggering (Loomis et  al., 2011; Wong and 
Choi, 2015). Interestingly, the delivery can be activated using 
in vivo signals, such as pH (Bigall et al., 2011; Sato et al., 2011), 
ion concentration, redox potential (Kang et al., 2010; Luo et al., 
2011), presence of certain enzymes (de la Rica et  al., 2012), 
and temperature (Kim and Lee, 2004). Exogenous triggering 
using nanomaterials responsive to light (Byoung-chan and Kun, 
2012), magnetic fields (Ge et al., 2012; Hawkins et al., 2012), or 
ultrasounds (Epstein-Barash et al., 2010) can be advantageous, 
since it can control the timing and degree of release (Ganta 
et al., 2008), thus minimizing the drug release at off-target sites 
(Rwei et al., 2015).
BiOiMAGinG TeCHniQUeS
Bioimaging gives morphological, anatomical, and physiologi-
cal information of biosamples and reports on the extension 
of the pathology and organ dysfunction, thus giving valuable 
information about selecting the best administration route of 
the elected drug (Naumova et  al., 2014; Dong et  al., 2015). 
Different non-invasive imaging techniques, differing in terms 
of sensitivity, resolution, data acquisition time, penetration 
TABLe 1 | Comparison of properties between different imaging 
techniques.
Technique Advantages Disadvantages example 
of UCnP 
application
LI •	 High sensitivity
•	 High spatial resolution
•	 Short acquisition times
•	 No ionizing radiation
•	 Real-time images
•	 Low cost
•	 Multiplexing
•	 High scattering
•	 Autofluorescence 
(NIR light 
avoids these 
drawbacks)
•	 Limited 
penetration 
depth (cm)
In vivo 
visualization of 
MCF-7 tumors 
(Zhu et al., 2014)
RI •	 High specificity
•	 High spatial resolution
•	 No photobleaching
•	 No autofluorescence
•	 No scattering
•	 No ionizing radiation
•	 Limited 
penetration 
depth (cm)
•	 Low sensitivity
•	 Long acquisition 
times
UCF-SERS 
dual mode tag 
for living cell 
and in vivo 
bioimaging (Niu 
et al., 2014)
CT •	 High spatial resolution
•	 Short acquisition times
•	 Unlimited penetration 
depth
•	 Moderately expensive
•	 Limited 
soft tissue 
discrimination
•	 Health risks 
(X-Ray)
In vivo imaging 
of different 
organs in a 
rat (Liu et al., 
2012a)
USI •	 High sensitivity
•	 High spatial resolution
•	 Short acquisition times
•	 No ionizing radiation
•	 Real-time images
•	 Low cost
•	 Limited 
penetration 
depth (cm)
•	 Operator 
dependent
LI and USI dual-
modality imaging 
(Jin et al., 2015)
PAI •	 High sensitivity
•	 High specificity
•	 No ionizing radiation
•	 Short acquisition times
•	 Low cost
•	 Moderate 
penetration 
depth
In vivo imaging 
of a mouse (Maji 
et al., 2014)
MRI •	 High specificity
•	 High spatial resolution
•	 No ionizing radiation
•	 High soft tissue 
contrast
•	 Unlimited penetration 
depth
•	 Limited sensitivity
•	 Long acquisition 
times
•	 Expensive
Angiography and 
atherosclerotic 
plaque imaging 
(Xing et al., 
2014)
NI •	 High sensitivity
•	 Unlimited penetration 
depth
•	 Short acquisition times
•	 Low spatial 
resolution
•	 Health risks 
(γ-rays)
•	 Expensive
Lymphatic 
system images 
of a mouse (Sun 
et al., 2011)
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depth, and costs, have been explored using NPs (Table 1) (Liu, 
2011; Roco et al., 2011; Gao et al., 2013; Naumova et al., 2014; 
Prodi et al., 2015).
Luminescence imaging
Light of an external source (UV–VIS–IR light) is absorbed by the 
contrast (emissive) agent (injected into the cell, tissue, or animal) 
and subsequently emitted at shorter or longer wavelengths. 
This low-cost method presents high sensitivity and enables fast 
analysis. Limitations of luminescence imaging (LI) are high light 
scattering and autofluorescence of the biological sample when 
using short wavelengths (UV and VIS light) (Sharma et al., 2006; 
Prodi et al., 2015; Wolfbeis, 2015).
Raman imaging
This is based on the Raman effect, which is the inelastic molecular 
scattering of incident light (Jokerst et  al., 2013). Raman imag-
ing (RI) has high specificity because each chemical bond has a 
characteristic vibrational energy. The absence of photobleaching 
and autofluorescence background when using NIR excitation 
makes this technique very promising in regenerative medicine 
(Gao et al., 2013). However, its weakness is its low photon effi-
ciency (less than one in a million incident photons corresponds to 
Raman scattering), resulting in weak signals and/or long acquisi-
tion times (Liu, 2011). To increase the signal, the Raman active 
molecules are placed on a metallic plasmonic surface, usually 
GNPs, due to their very strong surface enhancement capabilities 
when illuminated at the plasmon resonance band (Jokerst et al., 
2013). This technique is termed surface-enhanced Raman scat-
tering (SERS) (Jokerst et al., 2013).
X-Ray Computed Tomography
This is one of the most widely used tools in clinical diagnosis 
due to its availability, efficiency, and low cost. It directs X-rays 
to a biosample and measures the decrease in intensity along a 
linear path, obtaining cross sectional images (Law and Wong, 
2014). Computed tomography (CT) can provide anatomic and 
functional information of bones, organs, and tissues and is gener-
ally used in combination with other techniques, such as MRI and 
PET (Law and Wong, 2014). CT requires short acquisition time, 
has an unlimited penetration depth, and high spatial resolution; 
however, its weakness is that it has a limited soft tissue discrimi-
nation, and there are concerns on the health risks associated with 
X-ray radiation (McMahon and Currell, 2013).
Ultrasound imaging
These images are generated from pulsed sound waves reflected 
and transmitted between tissue structures, which are eventually 
detected as echoes (time response to travel back) (Naumova 
et  al., 2014). This technique allows real-time images, presents 
high sensitivity, and is low cost. However, its disadvantage is its 
limited penetration depth in tissues. In spite of that, this is one of 
the most commonly used techniques in clinical assays (Law and 
Wong, 2014).
Photoacoustic imaging
The absorbed energy from an external source (VIS–IR light) is 
transformed into kinetic energy of the sample through energy 
exchange processes, i.e., the incident light is converted into ultra-
sonic emission (Gao and Li, 2016). This technique hybridizes the 
high contrast and spectral selectivity of optical imaging with high 
ultrasonic resolution. It is a low cost and rapid technique, but has 
a moderate penetration depth (Prodi et al., 2015).
Magnetic Resonance imaging
It is based on the principles of nuclear magnetic resonance, which 
uses magnets to polarize the hydrogen nuclei in water molecules, 
thus obtaining a spatial distribution of signals emitted from 
protons in the tissue (Law and Wong, 2014). MRI is a popular 
technique for cellular imaging in large animals and humans 
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due to its high temporal and spatial contrast, high specificity, 
absence of ionizing radiation, and unlimited penetration depth. 
Unfortunately, MRI is expensive and needs a long time of analysis 
(Yeo et al., 2014).
nuclear imaging
Positron emission tomography and single photon emission com-
puted tomography (SPECT) use radionuclides (Law and Wong, 
2014). PET uses biologically active positron-emitting radiotrac-
ers (such as fluorine-18) that decay and cause the annihilation 
of a positron and an electron producing two γ-rays. This is one 
of the most sensitive methods for quantitative measurement of 
physiologic processes in  vivo (Law and Wong, 2014). SPECT 
consists of the emission of positrons to emit a single γ-ray, which 
is measured directly by rotating gamma cameras obtaining the 
image (Law and Wong, 2014). These methodologies possess high 
sensitivity and no limitations in penetration depth. The main 
drawbacks are the problems caused by the radiation, long acquisi-
tion times, and the presence of artifacts easily generated due to 
patient movement or bad distribution of the radiotracer (Law and 
Wong, 2014; Naumova et al., 2014).
UPCOnveRSiOn nAnOPARTiCLeS in 
BiOiMAGinG
Upconversion nanoparticles upconvert NIR light (800, 915, and 
980 nm) to multi-wavelength light (narrow emission bands at UV, 
visible, and even NIR region) using a low-power continuous-wave 
diode laser. NIR excitation allows for deep tissue penetration and 
avoids autofluorescence of the biological samples (i.e.,  higher 
sensitivity) (Philippot and Reiss, 2012; Dong et  al., 2015). 
Moreover, the possibility of using both NIR excitation and NIR 
emission (NIR-to-NIR upconversion) is particularly relevant for 
in vivo imaging of small animals, because it permits deep tissue 
penetration and less absorption and scattering of bio-tissues and 
organs. These properties combined with their high stability, low 
cytotoxicity (Gnach et al., 2015; Sun et al., 2015), good photosta-
bility, and non-photoblinking or -photobleaching make UCNPs 
unique optical tools for biological studies (Liu, 2011; DaCosta 
et al., 2014; Bünzli, 2015; Dong et al., 2015; Prodi et al., 2015). 
The only drawback of UCNPs in LI is their relatively low upcon-
version quantum yield; several strategies are being explored to 
enhance their emission yield (such as covering the UCNPs with 
an inorganic shell) (Chen et al., 2014a, 2015).
Though UCNPs have been mainly used in LI, recent studies 
have shown their versatility for other bioimaging techniques. 
PEG-capped NaYbF4:Er3+, Gd3+ NPs have been effectively inter-
nalized by HeLa cells and provided higher contrast images of a 
rat heart than equivalent concentrations of iobitridol (a current 
clinical contrast agent) (Liu et  al., 2012a). Moreover, UCNPs 
can be conveniently functionalized with iodinated compounds 
(silica-coated UCNPs with an iodine compound attached that 
absorbs X-ray radiation) to make them suitable for CT imaging 
(Zhang et al., 2011). These UCNPs allowed the visualization of a 
liver for 30 min, thus demonstrating their long circulating time. 
Moreover, hybrid BaYbF5 NPs perform well in the in vivo X-ray 
CT angiography (Liu et  al., 2012b). This binary CT agent was 
more efficient than iobitridol and allowed the visualization of the 
vasculature in an in vivo mouse model during 2 h.
Upconversion nanoparticles have also been studied as poten-
tial photoacoustic imaging (PAI) agents (Maji et al., 2014), using 
NaYF4:Yb3+, Er3+ NPs covered with α-cyclodextrin. Excitation 
at 980 nm of the nanosystem dispersed in water led to lumines-
cence quenching due to non-radiative relaxation processes and 
brought about an enhanced photoacoustic signal. The in  vivo 
localization of the UCNPs in mice showed their capability for 
PAI (Maji et al., 2014).
In addition, UCNPs containing Gd3+ as dopant and/or as 
host matrix have been studied as MRI contrast agents. For 
example, ultra-small NaGdF4 NPs have proved more efficient 
in MRI angiography and atherosclerotic plaque imaging than 
some commercial MRI contrast agents, and they were easily 
excreted by kidney (Xing et al., 2014). Furthermore, a chelating 
molecule [diethylenetriaminepentaacetic acid (DTPA)] was used 
to functionalize the surface of UCNPs with the aim of capturing 
potentially released Gd3+ ions, thus avoiding toxic effects in vivo 
(Xing et al., 2014). Also, Gd3+ can be incorporated in both, the NP 
as dopant ion and the ligand. Recent studies demonstrated that 
simultaneous internal and external incorporation of Gd3+ ions 
increase MRI sensitivity (Du et al., 2016).
Moreover, UCNPs can be used for multimodal imaging, i.e., 
the combination of two or more imaging techniques to benefit 
from their strengths and weaknesses (Chen et al., 2014a; DaCosta 
et al., 2014; Li et al., 2014a; Bünzli, 2015; Cheng and Lin, 2015; 
Christ and Schäferling, 2015; Dong et al., 2015; Park et al., 2015; 
Prodi et al., 2015; Rieffel et al., 2015a; Wu et al., 2015; Zhou et al., 
2015). There are examples of UCNPs in bimodal imaging com-
bining PET/LI (Sun et al., 2011), SPECT/LI (Yang et al., 2013), 
PAI/LI (Maji et  al., 2014), MRI/LI (Zhou et  al., 2010; Cheng 
et al., 2013a), CT/LI (Zhang et al., 2011; Liu et al., 2013a; Zheng 
et al., 2014), and ultrasound imaging (USI)/LI (Jin et al., 2015).
Thus, NaGdF4:Yb3+, Er3+, NPs functionalized with bovine 
serum albumin attached to DTPA-Gd3+ have proved useful in 
upconversion LI and MRI (Du et al., 2016). 18F radionuclide has 
been directly bound to the surface of NaYF4 UCNPs to generate 
a dual-model bioimaging technique, combining upconversion LI 
and PET imaging (Sun et al., 2011). Several prevalent diseases are 
associated with the lymphatic system, which is usually difficult to 
study by bioimaging due to the lack of techniques with adequate 
sensitivity and temporal resolution. Recently, NaYF4:Yb, Tm 
UCNPs have been labeled with 18F−, and the in  vivo mouse 
distribution of 18F-NaYF4:Yb, Tm UCNPs was monitored by 
upconversion LI. In addition, the mouse lymphatic system was 
imaged with ultra-high sensitivity by PET (Sun et  al., 2011). 
Moreover, a nanohybrid comprising NaYF4:Yb, Er, and Fe3O4 
NPs has shown versatile for upconversion LI and MRI. Mouse 
MSCs (mMSCs) were labeled with this nanohybrid, and the 
resulting nanoplatform was injected in mice with two wounds at 
opposite sides on the abdominal skin. Then, a magnet was placed 
on one of the wounds for 6 h to target magnetically the mMSCs 
at one of the wounds. The mMSCs were followed in vivo by LI 
and MRI, thus observing that the wound treated with mMSCs 
presented enhanced tissue repairing (Cheng et al., 2013a).
FiGURe 1 | Overview of UCnPs properties and reasons to apply them 
in regenerative medicine.
FiGURe 2 | (A) Schematic illustration of the utilization of SP-UCNP as a NIR-triggered photoswitch for non-invasive and reversible control of cell adhesion/
detachment by merely altering the power density of a single-wavelength 980-nm laser. Reprinted with permission from Li et al. (2015). Copyright (2015) American 
Chemical Society (Li et al., 2015). (B) Top: UCL image of a C56BL/6 mouse subcutaneously injected with various numbers of UCNPs labeled DCs (≈50–50,000). 
Middle: labeled DCs were injected into the rig; strong UCL signals from the draining lymph node were seen under in vivo UCL imaging. Bottom: ex vivo imaging of 
popliteal lymph nodes (white circles) before (top) and after (bottom) being dissected from the mouse. (C) Immunofluorescence images of the lymph nodes dissected 
from the mouse injected with UPP@OVA-labeled DCs. T: T-cell zone (Thy1.2+). B: B-cell zone (B220+). Scale bar = 20 μm. Arrows point to UCL signals from labeled 
DCs. Adapted with permission from Xiang et al. (2015). Copyright (2015) American Chemical Society (Xiang et al., 2015).
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In addition, examples of trimodal (Xing et  al., 2012; Cheng 
et al., 2013b; Ni et al., 2014; Wang et al., 2014a; Yi et al., 2015; Zhai 
et al., 2015), tetramodal (Sun et al., 2013), and even hexamodal 
(Rieffel et  al., 2015b) imaging by using UCNPs have also been 
reported.
UPCOnveRSiOn nAnOPARTiCLeS in 
ReGeneRATive MeDiCine
Near-infrared light is particularly attractive to monitor cell–surface 
interactions in regenerative medicine (Figure 1). NIR-controlled 
cell adhesion has been achieved with UCNP-based program-
mable substrates either by using photocaged linkers (Li  et  al., 
2014b) or via photoswitchable substrates (Li et  al., 2015). The 
UCNP harvested NIR light and converted it into UV light, thus 
inducing the cleavage of the photocaged linkers and on-demand 
release of adhesive cells (Li et  al., 2014b). This strategy not 
only enables deep tissue photocontrol of the cell adhesion on 
substrate but also opens a new approach to design UCNP-based 
cell scaffolds to manipulate dynamically cell–matrix and cell–cell 
interactions (Li et al., 2014b).
Cell-molecular recognition can be reversibly guided in 
interfacial systems by using photoswitching systems based 
on photoisomerization reactions (Weber et  al., 2014). In this 
context, UCNPs have been combined with photoswitchable 
systems such as spiropyrans (which converts to merocyanine 
after ring opening) (Zhang et al., 2012a,b; Chen et al., 2014b; Lai 
et al., 2014; Zhou et al., 2014), as well as diarylethenes (Boyer 
et  al., 2012; Yang et  al., 2014) and azobenzenes (cis/trans-
isomerization) (Liu et al., 2013b; Wang et al., 2014b). Recently, 
nanohybrids consisting of core–shell–shell–shell UCNPs, 
specifically, NaYF4:Tm,Yb@NaYF4@NaYF4:Er,Yb@NaYF4 NPs 
were coated with silica and conjugated afterward with spiro-
pyran (Figure  2A). This system has been described as a new 
generation of single-wavelength NIR-controlled photoswitches, 
which can control the efficient adhesion and detachment of cells 
reversibly and non-invasively (Li et al., 2015).
Upconversion nanoparticles are unique for live cell track-
ing because of their optical properties (Vetrone et  al., 2010; 
Tian et  al., 2012; Li et  al., 2013). Thus, silica/NaYF4:Yb, Er 
NPs loaded into cells were applied in cell migratory tracking 
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for 5  h by a time-lapse confocal microscope. The direction, 
speed, and cell–cell interaction of migrating cells were clearly 
visualized. Consequently, the nanoplatform could be used to 
track live myoblast cells in a living mouse model with cryo-
injured hind limb (Idris et al., 2009). Indeed polymer-coated 
UCNPs with different emission colors, aimed to multicolor 
in vivo upconversion LI, well performed in multiplexed lymph 
node mapping, and multicolor in  vivo cancer cell tracking 
(Cheng et al., 2010).
Even though UCNPs have relatively low upconversion 
efficiencies, they have shown ultrahigh sensitivity in  vivo stem 
cell tracking (Solanki et al., 2008; Cheng et al., 2013a; Gao et al., 
2013). In  addition, antigen-loaded UCNPs have recently been 
used to label and stimulate dendritic cells (DCs) to induce anti-
gen-specific immune response in vivo animals (Figures 2B,C). 
The homing of DCs to draining lymph nodes was monitored by 
impressively sensitive in vivo tracking of the NP-labeled DCs by 
upconversion LI (Xiang et al., 2015); a few DCs were enough to 
be clearly seen, while, comparatively, thousands of cells are usu-
ally needed to enable in vivo tracking in mice when using QDs 
and MNPs (Kraitchman et al., 2005; Yukawa et al., 2010).
It is worth noting that UCNPs can be used as multifunctional 
nanoplatforms for light-driven therapies, such as photothermal 
and photodynamic therapy, and spatiocontrolled drug delivery 
(Chen et al., 2014a; Shanmugam et al., 2014; Rwei et al., 2015). 
Therefore, it is presumed that they will become relevant in cell 
therapy, cell therapy combined with bioimaging, and by  extension 
in regenerative medicine.
COnCLUSiOn
Upconversion NPs have unique properties for their application 
in regenerative medicine. Specifically, they are considered non-
toxic; can exhibit NIR-to-visible upconversion luminescence 
and, more importantly, NIR-to-NIR upconversion luminescence; 
possess extraordinary (photo)stability; and can be designed 
with   additional features to make them useful tools for other 
bioimaging techniques or for multimodal imaging. Moreover, 
UCNPs are excellent candidates for multifunctional NP thera-
peutics, which can be triggered locally or remotely by NIR light. 
Thus, UCNPs can be relatively easily visualized in the body and 
can monitor the biological components and events, and/or may 
behave as functional scaffolds in the regeneration of damaged 
tissues and/or organs. Undoubtedly, UCNPs can be used for 
selective treatment of the affected area using photonics with 
simultaneous visualization of the process due to their multi-
wavelength emission.
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